Assembly Biosciences
ASMB • NASDAQ • Stock Fundamentals
Assembly Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jason A. Okazaki, with a market cap of $446.5M.
Market Cap$446.5M
Employees65.0
CEOJason A. Okazaki
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Assembly Biosciences FAQ
Common questions about Assembly Biosciences
Assembly Biosciences (ASMB) has a market capitalization of $446.5M and trades on NASDAQ.
Assembly Biosciences has approximately 65 employees.